Nonmotor symptoms in Parkinsons disease in 2012: Relevant clinical aspects

Parkinson's Disease

Volumn , Issue , 2012, Pages

  Bonnet, Anne Marie ^a   Jutras, Marie France ^a   Czernecki, Virginie ^a   Corvol, Jean Christophe ^a   Vidailhet, Marie ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANOSMIA; ANXIETY DISORDER; APATHY; BLADDER DYSFUNCTION; CONSTIPATION; DAYTIME SOMNOLENCE; DELIRIUM; DELUSION; DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSAUTONOMIA; DYSPHAGIA; DYSPNEA; ERYTHEMA; FATIGUE; HALLUCINATION; HUMAN; HYPOSMIA; ILLUSION; IMPULSE CONTROL DISORDER; INSOMNIA; MILD COGNITIVE IMPAIRMENT; NARCOLEPSY; ORTHOSTATIC HYPOTENSION; PAIN; PARKINSON DISEASE; PERIODIC LIMB MOVEMENT DISORDER; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; RESTLESS LEGS SYNDROME; REVIEW; SEXUAL DYSFUNCTION; SKIN MANIFESTATION; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SUBCUTANEOUS NODULE; VISUAL DISORDER; VOMITING; WANDERING BEHAVIOR; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 84864916034     PISSN: None     EISSN: 20420080     Source Type: Journal    
DOI: 10.1155/2012/198316     Document Type: Review

References (157)

1. Chaudhuri K. R., Healy D., Shapira A. H. V., The non motor symptoms of Parkinsons disease NMS Quest. Diagnosis and management The Lancet Neurology 2006 5 235 245
2. Martinez-Martin P., Rodriguez-Blazquez C., Abe K., Bhattacharyya K. B., Bloem B. R., Carod-Artal F. J., Prakash R., Esselink R. A. J., Falup-Pecurariu C., Gallardo M., Mir P., Naidu Y., Nicoletti A., Sethi K., Tsuboi Y., Van Hilten J. J., Visser M., Zappia M., Chaudhuri K. R., International study on the psychometric attributes of the Non-Motor Symptoms Scale in Parkinson disease Neurology 2009 73 19 1584 1591
3. Chaudhuri K. R., Odin P., Antonini A., Martinez-Martin P., Parkinson's disease: the non-motor issues Parkinsonism and Related Disorders 2011 17 10 717 723
4. Grosset D., Taurah L., Burn D. J., MacMahon D., Forbes A., Turner K., Bowron A., Walker R., Findley L., Foster O., Patel K., Clough C., Castleton B., Smith S., Carey G., Murphy T., Hill J., Brechany U., McGee P., Reading S., Brand G., Kelly L., Breen K., Ford S., Baker M., Williams A., Hearne J., Qizilbash N., Ray Chaudhuri K., A multicentre longitudinal observational study of changes in self reported health status in people with Parkinson's disease left untreated at diagnosis Journal of Neurology, Neurosurgery and Psychiatry 2007 78 5 465 469 (Pubitemid 46662892)
5. Tolosa E., Gaig C., Santamara J., Compta Y., Diagnosis and the premotor phase of Parkinson disease Neurology 2009 72 7, supplement 2 S12 S20
6. Witjas T., Kaphan E., Azulay J. P., Blin O., Ceccaldi M., Pouget J., Poncet M., Ali Chérif A., Nonmotor fluctuations in Parkinson's disease: frequent and disabling Neurology 2002 59 3 408 413 (Pubitemid 34857934)
7. Barone P., Antonini A., Colosimo C., Marconi R., Morgante L., Avarello T. P., Bottacchi E., Cannas A., Ceravolo G., Ceravolo R., Cicarelli G., Gaglio R. M., Giglia R. M., Iemolo F., Manfredi M., Meco G., Nicoletti A., Pederzoli M., Petrone A., Pisani A., Pontieri F. E., Quatrale R., Ramat S., Scala R., Volpe G., Zappulla S., Bentivoglio A. R., Stocchi F., Trianni G., Del Dotto P., The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease Movement Disorders 2009 24 11 1641 1649
8. O'Sullivan S. S., Williams D. R., Gallagher D. A., Massey L. A., Silveira-Moriyama L., Lees A. J., Nonmotor symptoms as presenting complaints in Parkinson's disease: a clinicopathological study Movement Disorders 2008 23 1 101 106 (Pubitemid 351281225)
9. Shulman L. M., Taback R. L., Bean J., Weiner W. J., Comorbity of the nonmotor symptoms of Parkinson's disease Movement Disorders 2001 16 3 507 510 (Pubitemid 36041156)
10. Martinez-Martin P., Shapira A. H. V., Stocchi F., Prevalence of non motor symptoms in Parkinsons disease in an international setting; study using non-motor symptoms questionnaire in 545 patients Movement Disorders 2007 22 1623 1629 (Pubitemid 47477925)
11. Wolters E. C., Non-motor extranigral signs and symptoms in Parkinson's disease Parkinsonism and Related Disorders 2009 15 3 S6 S12
12. Remy P., Doder M., Lees A., Turjanski N., Brooks D., Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system Brain 2005 128 6 1314 1322 (Pubitemid 40826185)
13. Chaudhuri K. R., Schapira A. H., Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment The Lancet Neurology 2009 8 5 464 474
14. Thobois S., Ardouin C., Schmitt E., Lhommée E., Klinger H., Xie J., Lagrange C., Kistner A., Aya Kombo M., Fleury V., Poisson A., Fraix V., Broussolle E., Pollak P., Krack P., Behavioral disorders in Parkinson's disease: from pathophysiology to the mastery of dopaminergic treatment Revue Neurologique 2010 166 10 816 821
15. Voon V., Fernagut P. O., Wickens J., Baunez C., Rodriguez M., Pavon N., Juncos J. L., Obeso J. A., Bezard E., Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders The Lancet Neurology 2009 8 12 1140 1149
16. Schrag A., Jahanshahi M., Quinn N., How does Parkinsons disease affect quality of life? A comparison with quality of life in the general population Movement Disorders 2000 15 1112 1118
17. Chaudhuri K. R., Martinez-Martin P., Brown R. G., Sethi K., Stocchi F., Odin P., Ondo W., Abe K., MacPhee G., MacMahon D., Barone P., Rabey M., Forbes A., Breen K., Tluk S., Naidu Y., Olanow W., Williams A. J., Thomas S., Rye D., Tsuboi Y., Hand A., Schapira A. H. V., The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an international pilot study Movement Disorders 2007 22 13 1901 1911 (Pubitemid 350134203)
18. Martinez-Martin P., Rodriguez-Blazquez C., Kurtis M. M., Chaudhuri K. R., The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease Movement Disorders 2011 26 3 399 406
19. Seppi K., Weintraub D., Coelho M., The movement Disorder Society Evidence-Based Medicine Review Update: treatments for the non-motor symptoms of Parkinsons disease Movement Disorders 2011 26 3 S42 S80
20. Tom T., Cummings J. L., Depression in Parkinson's disease. Pharmacological characteristics and treatment Drugs and Aging 1998 12 1 55 74 (Pubitemid 28033680)
21. Ravina B., Camicioli R., Como P. G., Marsh L., Jankovic J., Weintraub D., Elm J., The impact of depressive symptoms in early Parkinson disease Neurology 2007 69 4 342 347 (Pubitemid 47205660)
22. Cummings J. L., Depression and Parkinson's disease: a review American Journal of Psychiatry 1992 149 4 443 454
23. Reijnders J. S. A. M., Ehrt U., Weber W. E. J., Aarsland D., Leentjens A. F. G., A systematic review of prevalence studies of depression in Parkinson's disease Movement Disorders 2008 23 2 183 189 (Pubitemid 351311545)
24. Tan L. C. S., Mood disorders in Parkinsons disease Parkinsonism Related Disorders 2012 18, supplement 1 S74 S76
25. Devos D., Dujardin K., Poirot I., Moreau C., Cottencin O., Thomas P., Destée A., Bordet R., Defebvre L., Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study Movement Disorders 2008 23 6 850 857
26. Menza M., Dobkin R. D., Marin H., Mark M. H., Gara M., Buyske S., Bienfait K., Dicke A., A controlled trial of antidepressants in patients with Parkinson disease and depression Neurology 2009 72 10 886 892
27. Dobkin R. D., Menza M., Bienfait K. L., Gara M., Marin H., Mark M. H., Dicke A., Friedman J., Depression in Parkinson's disease: symptom improvement and residual symptoms after acute pharmacologic management American Journal of Geriatric Psychiatry 2011 19 3 222 229
28. Marsh L., Anxiety disorders in Parkinson's disease International Review of Psychiatry 2000 12 4 307 318
29. Nuti A., Ceravolo R., Piccini A., Psychiatric comorbidity in a population of Parkinsons disease patients European Journal of Neurology 2004 11 5 315 320 (Pubitemid 38903564)
30. Leentjens A. F., Dujardin K., Marsh L., Richard I. H., Starkstein S. E., Martinez-Martin P., Anxiety rating scales in Parkinson's disease: a validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale Movement Disorders 2011 26 3 407 415
31. Leentjens A. F. G., Dujardin K., Marsh L., Martinez-Martin P., Richard I. H., Starkstein S. E., Symptomatology and markers of anxiety disorders in Parkinson's disease: a cross-sectional study Movement Disorders 2011 26 3 484 492
32. Belzer K., Schneier F. R., Comorbidity of anxiety and depressive disorders: issues in conceptualization, assessment, and treatment Journal of Psychiatric Practice 2004 10 5 296 306 (Pubitemid 39299042)
33. Brown R. G., Depression and anxiety subtypes in PD Journal of Neurology, Neurosurgery Psychiatry 2011 82 7 803 809
34. Olanow C. W., Stern M. B., Sethi K., The scientific and clinical basis for the treatment of Parkinson disease (2009) Neurology 2009 72 21, supplement 4 S1 S136
35. Marin R. S., Apathy: a neuropsychiatric syndrome Journal of Neuropsychiatry and Clinical Neurosciences 1991 3 3 243 254
36. Starkstein S. E., Leentjens A. F. G., The nosological position of apathy in clinical practice Journal of Neurology, Neurosurgery and Psychiatry 2008 79 10 1088 1092
37. Starkstein S. E., Mayberg H. S., Preziosi T. J., Andrezejewski P., Leiguarda R., Robinson R. G., Reliability, validity, and clinical correlates of apathy in Parkinson's disease Journal of Neuropsychiatry and Clinical Neurosciences 1992 4 2 134 139
38. Sockeel P., Dujardin K., Devos D., Denve C., Destée A., Defebvre L., The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson's disease Journal of Neurology, Neurosurgery and Psychiatry 2006 77 5 579 584 (Pubitemid 43844578)
39. Benito-Len J., Cubo E., Coronell C., Impact of apathy on health-related quality of life in recently diagnosed Parkinson's disease: the ANIMO study Movement Disorders 2012 27 2 211 218
40. Levy R., Dubois B., Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits Cerebral Cortex 2006 16 7 916 928 (Pubitemid 43992442)
41. Kirsch-Darrow L., Fernandez H. F., Marsiske M., Okun M. S., Bowers D., Dissociating apathy and depression in Parkinson disease Neurology 2006 67 1 33 38 (Pubitemid 44305458)
42. Thobois S., Ardouin C., Lhommée E., Klinger H., Lagrange C., Xie J., Fraix V., Coelho Braga M. C., Hassani R., Kistner A., Juphard A., Seigneuret E., Chabardes S., Mertens P., Polo G., Reilhac A., Costes N., Lebars D., Savasta M., Tremblay L., Quesada J. L., Bosson J. L., Benabid A. L., Broussolle E., Pollak P., Krack P., Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation Brain 2010 133 4 1111 1127
43. Czernecki V., Pillon B., Houeto J. L., Pochon J. B., Levy R., Dubois B., Motivation, reward, and Parkinson's disease: influence of dopatherapy Neuropsychologia 2002 40 13 2257 2267 (Pubitemid 35303365)
44. Czernecki V., Schpbach M., Yaici S., Lévy R., Bardinet E., Yelnik J., Dubois B., Agid Y., Apathy following subthalamic stimulation in parkinson disease: a dopamine responsive symptom Movement Disorders 2008 23 7 964 969
45. Marin R. S., Fogel B. S., Hawkins J., Duffy J., Krupp B., Apathy: a treatable syndrome Journal of Neuropsychiatry and Clinical Neurosciences 1995 7 1 23 30
46. Weintraub D., Dopamine and impulse control disorders in Parkinson's disease Annals of Neurology 2008 64 2, supplement S93 S100
47. Weintraub D., Koester J., Potenza M. N., Siderowf A. D., Stacy M., Voon V., Whetteckey J., Wunderlich G. R., Lang A. E., Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients Archives of Neurology 2010 67 5 589 595
48. Evans A. H., Lees A. J., Dopamine dysregulation syndrome in Parkinsons disease Current Opinion in Neurology 2004 17 4 493 398
49. Voon V., Fox S. H., Medication-related impulse control and repetitive behaviors in Parkinson disease Archives of Neurology 2007 64 8 1089 1096 (Pubitemid 47258066)
50. Pontone G., Williams J. R., Bassett S. S., Marsh L., Clinical features associated with impulse control disorders in Parkinson disease Neurology 2006 67 7 1258 1261 (Pubitemid 44563839)
51. Nirenberg M. J., Waters C., Compulsive eating and weight gain related to dopamine agonist use Movement Disorders 2006 21 4 524 529
52. Miyasaki J. M., Al Hassan K., Lang A. E., Voon V., Punding prevalence in Parkinson's disease Movement Disorders 2007 22 8 1179 1181 (Pubitemid 47067232)
53. Lawrence A. J., Blackwell A. D., Barker R. A., Spagnolo F., Clark L., Aitken M. R. F., Sahakian B. J., Predictors of punding in Parkinson's disease: results from a questionnaire survey Movement Disorders 2007 22 16 2339 2345 (Pubitemid 351155978)
54. Weintraub D., Siderowf A. D., Potenza M. N., Goveas J., Morales K. H., Duda J. E., Moberg P. J., Stern M. B., Association of dopamine agonist use with impulse control disorders in Parkinson disease Archives of Neurology 2006 63 7 969 973 (Pubitemid 44036299)
55. Voon V., Mehta A. R., Hallett M., Impulse control disorders in Parkinson's disease: recent advances Current Opinion in Neurology 2011 24 4 324 330
56. Voon V., Sohr M., Lang A. E., Impulse control disorders in Parkinsons disease: a multicentrer case-control study Annals of Neurology 2011 69 6 986 996
57. Weintraub D., Stewart S., Shea J. A., Validation of the questionnaire for impulsive-compulsive behaviors in Parkinsons disease (QUIP) Movement Disorders 2009 24 1461 1467
58. Ardouin C., Chéreau I., Llorca P. M., Lhommée E., Durif F., Pollak P., Krack P., Assessment of hyper- and hypodopaminergic behaviors in Parkinson's disease Revue Neurologique 2009 165 11 845 856
59. Cilia R., Siri C., Marotta G., Isaias I. U., De Gaspari D., Canesi M., Pezzoli G., Antonini A., Functional abnormalities underlying pathological gambling in parkinson disease Archives of Neurology 2008 65 12 1604 1611
60. Van Eimeren T., Pellecchia G., Cilia R., Ballanger B., Steeves T. D. L., Houle S., Miyasaki J. M., Zurowski M., Lang A. E., Strafella A. P., Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD Neurology 2010 75 19 1711 1716
61. Voon V., Pessiglione M., Brezing C., Gallea C., Fernandez H. H., Dolan R. J., Hallett M., Mechanisms Underlying Dopamine-Mediated Reward Bias in Compulsive Behaviors Neuron 2010 65 1 135 142
62. Carter A., Ambermoon P., Hall W. D., Drug-induced impulse control disorders: a prospectus for neuroethical analysis Neuroethics 2011 4 2 91 102
63. Mamikonyan E., Siderowf A. D., Duda J. E., Potenza M. N., Horn S., Stern M. B., Weintraub D., Long-term follow-up of impulse control disorders in Parkinson's disease Movement Disorders 2008 23 1 75 80 (Pubitemid 351281221)
64. Dubois B., Pillon B., Cognitive deficits in Parkinson's disease Journal of Neurology 1997 244 1 2 8 (Pubitemid 26413891)
65. Aarsland D., Zaccai J., Brayne C., A systematic review of prevalence studies of dementia in Parkinson's disease Movement Disorders 2005 20 10 1255 1263 (Pubitemid 41645899)
66. De Lau L. M. L., Schipper C. M. A., Hofman A., Koudstaal P. J., Breteler M. M. B., Prognosis of parkinson disease. Risk of dementia and mortality: the rotterdam study Archives of Neurology 2005 62 8 1265 1269 (Pubitemid 41168354)
67. Hughes T. A., Ross H. F., Musa S., Bhattacherjee S., Nathan R. N., Mindham R. H. S., Spokes E. G. S., A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease Neurology 2000 54 8 1596 1602 (Pubitemid 30226802)
68. Aarsland D., Andersen K., Larsen J. P., Lolk A., Nielsen H., Kragh-Srensen P., Risk of dementia in Parkinson's disease: a community-based, prospective study Neurology 2001 56 6 730 736 (Pubitemid 32240091)
69. Bohnen N. I., Kaufer D. I., Ivanco L. S., Lopresti B., Koeppe R. A., Davis J. G., Mathis C. A., Moore R. Y., DeKosky S. T., Cortical cholinergic function is more severely affected in Parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study Archives of Neurology 2003 60 12 1745 1748 (Pubitemid 37521630)
70. Aarsland D., Mosimann U. P., McKeith I. G., Role of cholinesterase inhibitors in Parkinson's disease and dementia with Lewy bodies Journal of Geriatric Psychiatry and Neurology 2004 17 3 164 171 (Pubitemid 39128226)
71. Cummings J. L., Wolters E. C., Scheltens P., Psychosis in basal ganglia disorders Mental Dysfunction in Parkinsons Disease 1993 Amsterdam, The Netherlands Vriije Universiteit
72. Forsaa E. B., Larsen J. P., Wentzel-Larsen T., Goetz C. G., Stebbins G. T., Aarsland D., Alves G., A 12-year population-based study of psychosis in Parkinson disease Archives of Neurology 2010 67 8 996 1001
73. Fénelon G., Mahieux F., Huon R., Ziégler M., Hallucinations in Parkinson's disease. Prevalence, phenomenology and risk factors Brain 2000 123 4 733 745 (Pubitemid 30162723)
74. Fenelon G., Alves G., Epidemiology of psychosis in Parkinsons disease Journal of the Neurological Sciences 2010 289 1-2 12 17
75. Diederich N. J., Goetz C. G., Raman R., Pappert E. J., Leurgans S., Piery V., Poor visual discrimination and visual hallucinations in Parkinson's disease Clinical Neuropharmacology 1998 21 5 289 295 (Pubitemid 28491429)
76. Arnulf I., Bonnet A. M., Damier P., Bejjani B. P., Seilhean D., Derenne J. P., Agid Y., Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis Neurology 2000 55 2 281 288 (Pubitemid 30604632)
77. Factor S. A., Feustel P. J., Friedman J. H., Comella C. L., Goetz C. G., Kurlan R., Parsa M., Pfeiffer R., Longitudinal outcome of Parkinson's disease patients with psychosis Neurology 2003 60 11 1756 1761 (Pubitemid 36737069)
78. Levy G., Tang M. X., Louis E. D., Cté L. J., Alfaro B., Mejia H., Stern Y., Marder K., The association of incident dementia with mortality in PD Neurology 2002 59 11 1708 1713 (Pubitemid 35424451)
79. Fénelon G., Psychosis in Parkinson's disease: phenomenology, frequency, risk factors, and current understanding of pathophysiologic mechanisms CNS Spectrums 2008 13 3 18 25 (Pubitemid 351532445)
80. Ibarretxe-Bilbao N., Junque C., Marti M. J., Tolosa E., Cerebral basis of visual hallucinations in Parkinson's disease: structural and functional MRI studies Journal of the Neurological Sciences 2011 310 1 79 81
81. Ramrez-Ruiz B., Mart M. J., Tolosa E., Bartrés-Faz D., Summerfield C., Salgado-Pineda P., Gmez-Ansn B., Junqué C., Longitudinal evaluation of cerebral morphological changes in Parkinson's disease with and without dementia Journal of Neurology 2005 252 11 1345 1352 (Pubitemid 41699025)
82. Williams D. R., Lees A. J., Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study Lancet Neurology 2005 4 10 605 610 (Pubitemid 41317294)
83. Friedman J. H., Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease New England Journal of Medicine 1999 340 10 757 763 (Pubitemid 29114294)
84. Koller W. C., Sensory symptoms in Parkinson's disease Neurology 1984 34 7 957 959 (Pubitemid 14076465)
85. Lee M. A., Walker R. W., Hildreth T. J., Prentice W. M., A survey of pain in idiopathic Parkinson's disease Journal of Pain and Symptom Management 2006 32 5 462 469 (Pubitemid 44666294)
86. Defazio G., Berardelli A., Fabbrini G., Martino D., Fincati E., Fiaschi A., Moretto G., Abbruzzese G., Marchese R., Bonuccelli U., Del Dotto P., Barone P., De Vivo E., Albanese A., Antonini A., Canesi M., Lopiano L., Zibetti M., Nappi G., Martignoni E., Lamberti P., Tinazzi M., Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study Archives of Neurology 2008 65 9 1191 1194
87. Ngre-Pags L., Regragui W., Bouhassira D., Grandjean H., Rascol O., Chronic pain in Parkinson's disease: the cross-sectional French DoPaMiP survey Movement Disorders 2008 23 10 1361 1369
88. Goetz C. G., Tanner C. M., Levy M., Wilson R. S., Garron D. C., Pain in Parkinsons disease Movement Disorders 1986 1 45 49
89. Ford B., Pain in Parkinson's disease Clinical Neuroscience 1998 5 2 63 72
90. Ha A. D., Jankovic J., Pain in Parkinsons disease Movement Disorders 2012 27 4 485 491
91. Beiske A. G., Loge J. H., Rnningen A., Svensson E., Pain in Parkinson's disease: prevalence and characteristics Pain 2009 141 1-2 173 177
92. Djaldetti R., Shifrin A., Rogowski Z., Sprecher E., Melamed E., Yarnitsky D., Quantitative measurement of pain sensation in patients with Parkinson disease Neurology 2004 62 12 2171 2175 (Pubitemid 38787770)
93. Brefel-Courbon C., Payoux P., Thalamas C., Ory F., Quelven I., Chollet F., Montastruc J. L., Rascol O., Effects of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study Movement Disorders 2005 20 12 1557 1563
94. Lavreysen H., Dautzenberg F. M., Therapeutic potential of group III metabotropic glutamate receptors Current Medicinal Chemistry 2008 15 7 671 684 (Pubitemid 351516803)
95. Djaldetti R., Yust-Katz S., Kolianov V., Melamed E., Dabby R., The effect of duloxetine on primary pain symptoms in Parkinson disease Clinical Neuropharmacology 2007 30 4 201 205 (Pubitemid 47356716)
96. Barone P., Antonini A., Colossimo C., Marconi R., The PRIAMO Study: a multicenter assessment of non motor symptoms and their impact on quality of life in Parkinsons disease Movement Disorders 2009 24 11 1641 1649
97. Arnulf I., Konofal E., Merino-Andreu M., Houeto J. L., Mesnage V., Welter M. L., Lacomblez L., Golmard J. L., Derenne J. P., Agid Y., Parkinson's disease and sleepiness: an integral part of PD Neurology 2002 58 7 1019 1024 (Pubitemid 34298539)
98. Garcia-Borreguero D., Odin P., Serrano C., Restless legs syndrome and PD: a review of the evidence for a possible association Neurology 2003 61 6, supplement 3 S49 S55
99. Arnulf I., Leu S., Oudiette D., Abnormal sleep and sleepiness in Parkinson's disease Current Opinion in Neurology 2008 21 4 472 477
100. Iranzo A., Lomea F., Stockner H., Valldeoriola F., Vilaseca I., Salamero M., Molinuevo J. L., Serradell M., Duch J., Pava J., Gallego J., Seppi K., Hgl B., Tolosa E., Poewe W., Santamaria J., Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study The Lancet Neurology 2010 9 11 1070 1077
101. Pal P. K., Calne S., Samii A., Fleming J. A. E., A review of normal sleep and its disturbances in Parkinson's disease Parkinsonism and Related Disorders 1999 5 1-2 1 17 (Pubitemid 29256362)
102. Tandberg E., Larsen J. P., Karlsen K., Excessive daytime sleepiness and sleep benefit in Parkinsons disease: a community-based study Movement Disorders 1999 14 922 927
103. Diederich N. J., McIntyre D. J., Sleep disorders in Parkinsons disease: many causes, few therapeutic options Journal of the Neurological Sciences 2011 314 1-2 12 19
104. Barone P., Amboni M., Vitale C., Bonavita V., Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease Neurology 2004 63 8 S35 S38
105. Post K. K., Singer C., Papapetropoulos S., Cardiac denervation and dysautonomia in Parkinson's disease: a review of screening techniques Parkinsonism and Related Disorders 2008 14 7 524 531
106. Visser M., Marinus J., Stiggelbout A. M., van Hilten J. J., Assessment of autonomic dysfunction in Parkinson's disease: the SCOPA-AUT Movement Disorders 2004 19 11 1306 1312 (Pubitemid 39534547)
107. Sakakibara R., Uchiyama T., Yamanishi T., Kishi M., Genitourinary dysfunction in Parkinson's disease Movement Disorders 2010 25 1 2 12
108. Sakakibara R., Shinotoh H., Uchiyama T., Sakuma M., Kashiwado M., Yoshiyama M., Hattori T., Questionnaire-based assessment of pelvic organ dysfunction in Parkinson's disease Autonomic Neuroscience 2001 92 1-2 76 85 (Pubitemid 32757250)
109. Gao X., Chen H., Schwarzschild M. A., Glasser D. B., Logroscino G., Rimm E. B., Ascherio A., Erectile function and risk of Parkinson's disease American Journal of Epidemiology 2007 166 12 1446 1450 (Pubitemid 350209051)
110. Lahrmann H., Cortelli P., Hilz M., Mathias C. J., Struhal W., Tassinari M., EFNS guidelines on the diagnosis and management of orthostatic hypotension European Journal of Neurology 2006 13 9 930 936 (Pubitemid 44284897)
111. Senard J. M., Pathak A., Neurogenic orthostatic hypotension of Parkinson's disease: what exploration for what treatment? Revue Neurologique 2010 166 10 779 784
112. Senard J. M., Ra S., Lapeyre-Mestre M., Brefel C., Rascol O., Rascol A., Montastruc J. L., Prevalence of orthostatic hypotension in Parkinson's disease Journal of Neurology Neurosurgery and Psychiatry 1997 63 5 584 589 (Pubitemid 27489221)
113. Senard J. M., Valet P., Durrieu G., Berlan M., Tran M. A., Montastruc J. L., Rascol A., Montastruc P., Adrenergic supersensitivity in Parkinsonians with orthostatic hypotension European Journal of Clinical Investigation 1990 20 6 613 619
114. Senard J. M., Brefel-Courbon C., Rascol O., Montastruc J. L., Orthostatic hypotension in patients with Parkinson's disease: pathophysiology and management Drugs and Aging 2001 18 7 495 505 (Pubitemid 32664724)
115. Allcock L. M., Kenny R. A., Burn D. J., Clinical phenotype of subjects with Parkinson's disease orthostatic hypotension: autonomic symptom and demographic comparison Movement Disorders 2006 21 11 1851 1855 (Pubitemid 44848930)
116. Savica R., Carlin J. M., Grossardt B. R., Bower J. H., Ahlskog J. E., Maraganore D. M., Bharucha A. E., Rocca W. A., Medical records documentation of constipation preceding Parkinson disease: a case-control study Neurology 2009 73 21 1752 1758
117. Abbott R. D., Petrovitch H., White L. R., Masaki K. H., Tanner C. M., Curb J. D., Grandinetti A., Blanchette P. L., Popper J. S., Ross G. W., Frequency of bowel movements and the future risk of Parkinson's disease Neurology 2001 57 3 456 462 (Pubitemid 32757593)
118. Sakakibara R., Uchiyama T., Yamanishi T., Shirai K., Hattori T., Bladder and bowel dysfunction in Parkinson's disease Journal of Neural Transmission 2008 115 3 443 460
119. Stacy M., Hauser R., Development of a patient questionnaire to facilitate recognition of motor and non-motor wearing-off in Parkinson's disease Journal of Neural Transmission 2007 114 2 211 217 (Pubitemid 46147158)
120. Bayulkem K., Lopez G., Non motor fluctuatons in Parkinsons disease: clinical spectrum and classification Journal of the Neurological Sciences 2010 289 89 92
121. Fox S. H., Lang A. E., Motor and non-motor fluctuations Handbook of Clinical Neurology 2007 84 157 184
122. Riley D. E., Lang A. E., The spectrum of levodopa-related fluctuations in Parkinson's disease Neurology 1993 43 8 1459 1464 (Pubitemid 23230524)
123. Chaudhuri K. R., Martinez-Martin P., Schapira A. H. V., Stocchi F., Sethi K., Odin P., Brown R. G., Koller W., Barone P., MacPhee G., Kelly L., Rabey M., MacMahon D., Thomas S., Ondo W., Rye D., Forbes A., Tluk S., Dhawan V., Bowron A., Williams A. J., Olanow C. W., International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study Movement Disorders 2006 21 7 916 923 (Pubitemid 44184590)
124. Martinez-Martin P., Rodriguez-Blazquez C., Abe K., Bhattacharyya K. B., Bloem B. R., Carod-Artal F. J., Prakash R., Esselink R. A. J., Falup-Pecurariu C., Gallardo M., Mir P., Naidu Y., Nicoletti A., Sethi K., Tsuboi Y., Van Hilten J. J., Visser M., Zappia M., Chaudhuri K. R., International study on the psychometric attributes of the Non-Motor Symptoms Scale in Parkinson disease Neurology 2009 73 19 1584 1591
125. Gallagher D. A., Lees A. J., Schrag A., What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them? Movement Disorders 2010 25 15 2493 2500
126. Chaudhuri K. R., Martinez-Martin P., Brown R. G., Sethi K., Stocchi F., Odin P., Ondo W., Abe K., MacPhee G., MacMahon D., Barone P., Rabey M., Forbes A., Breen K., Tluk S., Naidu Y., Olanow W., Williams A. J., Thomas S., Rye D., Tsuboi Y., Hand A., Schapira A. H. V., The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an international pilot study Movement Disorders 2007 22 13 1901 1911 (Pubitemid 350134203)
127. Marinus J., Visser M., Stiggelbout A. M., Rabey J. M., Bonuccelli U., Kraus P. H., Van Hilten J. J., Activity-based diary for Parkinson's disease Clinical Neuropharmacology 2002 25 1 43 50 (Pubitemid 34178248)
128. Visser M., Marinus J., Stiggelbout A. M., van Hilten J. J., Assessment of autonomic dysfunction in Parkinson's disease: the SCOPA-AUT Movement Disorders 2004 19 11 1306 1312 (Pubitemid 39534547)
129. Verbaan D., Marinus J., Visser M., Van Rooden S. M., Stiggelbout A. M., Van Hilten J. J., Patient-reported autonomic symptoms in Parkinson disease Neurology 2007 69 4 333 341 (Pubitemid 47205659)
130. Rendas-Baum R., Buck P. O., White M. K., Castelli-Haley J., Psychometric validation of the revised SCOPA-Diary Card: expanding the measurement of non-motor symptoms in Parkinsons disease Health and Quality of Life Outcomes 2011 9, article 69
131. Goetz C. G., Tilley B. C., Shaftman S. R., Stebbins G. T., Fahn S., Martinez-Martin P., Poewe W., Sampaio C., Stern M. B., Dodel R., Dubois B., Holloway R., Jankovic J., Kulisevsky J., Lang A. E., Lees A., Leurgans S., LeWitt P. A., Nyenhuis D., Olanow C. W., Rascol O., Schrag A., Teresi J. A., van Hilten J. J., LaPelle N., Agarwal P., Athar S., Bordelan Y., Bronte-Stewart H. M., Camicioli R., Chou K., Cole W., Dalvi A., Delgado H., Diamond A., Dick J. P., Duda J., Elble R. J., Evans C., Evidente V. G., Fernandez H. H., Fox S., Friedman J. H., Fross R. D., Gallagher D., Goetz C. G., Hall D., Hermanowicz N., Hinson V., Horn S., Hurtig H., Kang U. J., Kleiner-Fisman G., Klepitskaya O., Kompoliti K., Lai E. C., Leehey M. L., Leroi I., Lyons K. E., McClain T., Metzer S. W., Miyasaki J., Morgan J. C., Nance M., Nemeth J., Pahwa R., Parashos S. A., Schneider J. S. J. S., Schrag A., Sethi K., Shulman L. M., Siderowf A., Silverdale M., Simuni T., Stacy M., Stern M. B., Stewart R. M., Sullivan K., Swope D. M., Wadia P. M., Walker R. W., Walker R., Weiner W. J., Wiener J., Wilkinson J., Wojcieszek J. M., Wolfrath S., Wooten F., Wu A., Zesiewicz T. A., Zweig R. M., Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results Movement Disorders 2008 23 15 2129 2170
132. Gallagher D. A., Goetz C. G., Stebbins G., Lees A. J., Schrag A., Validation of the MDS-UPDRS Part 1 for nonmotor symptoms in Parkinsons disease Movement Disorders 2012 27 1 79 83
133. Kleiner-Fisman G., Martine R., Lang A. E., Stern M. B., Development of a non-motor fluctuation assessment instrument for Parkinsons disease Parkinsonism Related Disorders 2011 2011 13
134. Hgl B., Arnulf I., Comella C., Ferreira J., Iranzo A., Tilley B., Trenkwalder C., Poewe W., Rascol O., Sampaio C., Stebbins G. T., Schrag A., Goetz C. G., Scales to assess sleep impairment in Parkinson's disease: critique and recommendations Movement Disorders 2010 25 16 2704 2716
135. Weintraub D., Hoops S., Shea J. A., Lyons K. E., Pahwa R., Driver-Dunckley E. D., Adler C. H., Potenza M. N., Miyasaki J., Siderowf A. D., Duda J. E., Hurtig H. I., Colcher A., Horn S. S., Stern M. B., Voon V., Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease Movement Disorders 2009 24 10 1461 1467
136. Lang A. E., A critical appraisal of the premotor symptoms of Parkinson's disease: potential usefulness in early diagnosis and design of neuroprotective trials Movement Disorders 2011 26 5 775 783
137. Tolosa E., Gaig C., Santamara J., Compta Y., Diagnosis and the premotor phase of Parkinson disease Neurology 2009 72 7 S12 S20
138. Ponsen M. M., Stoffers D., Booij J., Van Eck-Smit B. L. F., Wolters E. C., Berendse H. W., Idiopathic hyposmia as a preclinical sign of Parkinson's disease Annals of Neurology 2004 56 2 173 181 (Pubitemid 39037913)
139. Ross G. W., Petrovitch H., Abbott R. D., Tanner C. M., Popper J., Masaki K., Launer L., White L. R., Association of olfactory dysfunction with risk for future Parkinson's disease Annals of Neurology 2008 63 2 167 173 (Pubitemid 351355295)
140. Abbott R. D., Ross G. W., Petrovitch H., Tanner C. M., Davis D. G., Masaki K. H., Launer L. J., Curb J. D., White L. R., Bowel movement frequency in late-life and incidental lewy bodies Movement Disorders 2007 22 11 1581 1586 (Pubitemid 47477919)
141. Braak H., Bohl J. R., Mller C. M., Rb U., de Vos R. A. I., Del Tredici K., Stanley Fahn lecture 2005: the staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered Movement Disorders 2006 21 12 2042 2051 (Pubitemid 46140410)
142. Lebouvier T., Chaumette T., Damier P., Coron E., Touchefeu Y., Vrignaud S., Naveilhan P., Galmiche J. P., Bruley Des Varannes S., Derkinderen P., Neunlist M., Pathological lesions in colonic biopsies during Parkinson's disease Gut 2008 57 12 1741 1743
143. Leentjens A. F. G., Van Den Akker M., Metsemakers J. F. M., Lousberg R., Verhey F. R. J., Higher incidence of depression preceding the onset of parkinson's disease: a register study Movement Disorders 2003 18 4 414 418 (Pubitemid 36527282)
144. Tandberg E., Larsen J. P., Karlsen K., A community-based study of sleep
145. Kumar S., Bhatia M., Behari M., Sleep disorders in Parkinson's disease Movement Disorders 2002 17 4 775 781 (Pubitemid 41295024)
146. Iranzo A., Molinuevo J. L., Santamara J., Serradell M., Mart M. J., Valldeoriola F., Tolosa E., Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study Lancet Neurology 2006 5 7 572 577 (Pubitemid 43867426)
147. Iranzo A., Lomea F., Stockner H., Valldeoriola F., Vilaseca I., Salamero M., Molinuevo J. L., Serradell M., Duch J., Pava J., Gallego J., Seppi K., Hgl B., Tolosa E., Poewe W., Santamaria J., Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study The Lancet Neurology 2010 9 11 1070 1077
148. Postuma R. B., Montplaisir J., Predicting Parkinson's diseasewhy, when, and how? Parkinsonism and Related Disorders 2009 15 3 S105 S109
149. Braak H., Del Tredici K., Rb U., De Vos R. A. I., Jansen Steur E. N. H., Braak E., Staging of brain pathology related to sporadic Parkinson's disease Neurobiology of Aging 2003 24 2 197 211 (Pubitemid 36007810)
150. Forno L. S., Neuropathology of Parkinson's disease Journal of Neuropathology and Experimental Neurology 1996 55 3 259 272 (Pubitemid 26085575)
151. Chaudhuri K. R., Prieto-Jurcynska C., Naidu Y., Mitra T., Frades-Payo B., Tluk S., Ruessmann A., Odin P., Macphee G., Stocchi F., Ondo W., Sethi K., Schapira A. H. V., Castrillo J. C. M., Martinez-Martin P., The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire Movement Disorders 2010 25 6 704 709
152. Shulman L. M., Taback R. L., Rabinstein A. A., Weiner W. J., Non-recognition of depression and other non-motor symptoms in Parkinson's disease Parkinsonism and Related Disorders 2002 8 3 193 197 (Pubitemid 33091403)
153. Martinez-Martin P., Rodriguez-Blazquez C., Kurtis M. M., Chaudhuri K. R., The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease Movement Disorders 2011 26 3 399 406
154. Leonardi M., Raggi A., Pagani M., Relationship between disability, quality of life and prevalence of non motor symptoms in Parkinsons disease Parkinsonism Related Disorders 2012 18 1 35 39
155. Hinnel C., Hurt C. S., Landau S., Brown R. G., Samuel M., Non-motor versus motor symptoms: how much do they matter to health status in Parkinsons disease Movement Disorders 2011 27 2 236 241
156. Visser M., Van Rooden S. M., Verbaan D., Marinus J., Stiggelbout A. M., Van Hilten J. J., A comprehensive model of health-related quality of life in Parkinson's disease Journal of Neurology 2008 255 10 1580 1587
157. Zesiewicz T. A., Sullivan K. L., Arnulf I., Chaudhuri K. R., Morgan J. C., Gronseth G. S., Miyasaki J., Iverson D. J., Weiner W. J., Practice parameter: treatment of nonmotor symptoms of Parkinson disease: report of the quality standards subcommittee of the American academy of neurology Neurology 2010 74 11 924 931